MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical firm in the healthcare sector, is gaining attention from investors due to its promising pipeline and potential upside. With a market capitalization of $1.3..
For investors eyeing opportunities in the healthcare sector, Harrow, Inc. (NASDAQ: HROW) presents a compelling case for consideration. With a market capitalization of $1.1 billion, this Nashville-based eyecare pharmaceutical company..
Investors with an eye on the biotechnology sector may want to take a closer look at Viridian Therapeutics, Inc. (NASDAQ: VRDN), a company that is making significant strides in the..
Brookdale Senior Living Inc. (NYSE: BKD), a key player in the healthcare sector specializing in medical care facilities, is drawing attention from investors due to its significant potential upside of..
Investors looking into the healthcare sector may find agilon health, inc. (NYSE: AGL) an intriguing prospect, particularly with its projected potential upside of 89.05%. Despite its current challenges, agilon health..
Evolent Health, Inc. (NYSE: EVH) is making waves within the healthcare sector, specifically in the health information services industry. With a market capitalization of $888.72 million, the company has carved..
Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology firm based in Singapore, is capturing investor attention with its promising pipeline of RNA therapies and an impressive potential upside. Currently trading..
The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector, particularly within the medical care facilities industry. With a focus on providing essential services through its two..
Healthcare Services Group, Inc. (NASDAQ: HCSG) stands as a notable entity in the healthcare sector, providing a range of essential services across the United States. Despite current market volatility, HCSG..
Pacira BioSciences, Inc. (NASDAQ: PCRX), a key player in the healthcare sector specializing in non-opioid pain management, presents an intriguing opportunity for investors seeking exposure to innovative drug manufacturing. With..
Investors with an eye on the healthcare sector may find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing candidate, particularly given the company’s substantial potential upside of over 55%. Operating within the..
Investors with an eye on the healthcare sector may find Opko Health, Inc. (NASDAQ: OPK) an intriguing prospect. With a market capitalization of $1.09 billion, this Miami-based company operates across..
As investors navigate the challenging landscape of healthcare stocks, 10x Genomics, Inc. (NASDAQ: TXG) presents a compelling case for consideration, especially with the potential upside of 31.90% based on current..
Investors with a keen eye on the healthcare sector may want to take a closer look at Indivior PLC (INDV), a prominent player in the specialty and generic drug manufacturing..
Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company specializing in vaccines, presents an intriguing investment opportunity for those looking to navigate the healthcare sector. With a current market capitalization of..
In the ever-evolving landscape of healthcare, Kestra Medical Technologies, Ltd. (KMTS) has emerged as a noteworthy player with a unique focus on wearable medical devices. As the company continues to..
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Despite recent challenges reflected..
Pulse Biosciences, Inc. (NASDAQ: PLSE), a notable player in the healthcare sector, has carved a niche for itself as a pioneer in the field of bioelectric medicine. With a market..
Investors focusing on the healthcare sector might find Bausch Health Companies Inc. (NYSE: BHC) a compelling opportunity, particularly due to the potential 58.11% upside based on the average target price...
Individual investors seeking opportunities in the biotechnology sector may find Biohaven Ltd. (BHVN) an intriguing prospect. With its focus on cutting-edge therapies in immunology, neuroscience, and oncology, Biohaven’s pipeline is..
